2,4-Dichloro-5,7-dihydrothieno[3,4-d]pyrimidine – (74901-71-6)

piracetam, 7491-74-9, 2-(2-oxopyrrolidin-1-yl)acetamide, Nootropil, 2-Oxo-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, 2-oxo-, Nootropyl, Pyracetam, Normabrain, Gabacet, Pyramem, Ciclofalina, Euvifor, Genogris, Nootron, Pirazetam, Pirroxil, 2-Pyrrolidinoneacetamide, Myocalm, 2-Pyrrolidoneacetamide, 2-Oxo-pyrrolidine acetamide, Piracetamum, Breinox, Naofukang, Cl-871, 1-Acetamido-2-pyrrolidinone, 2-Oxo-pyrrolidin-1-ylacetamide, 2-Ketopyrrolidine-1-ylacetamide, UCB 6215, 2-(2-oxo-pyrrolidin-1-yl)acetamide, KT-801, UCB-6215, EINECS 231-312-7, UNII-ZH516LNZ10, NSC-758191, BRN 1526393, ZH516LNZ10, MLS000069719, HSDB 7529, MFCD00079246, SMR000058196, 2-(2-Oxopyrrolidino)acetamide, DTXSID5044491, 5-21-06-00360 (Beilstein Handbook Reference), NSC 758191, NCGC00015821-02, CAS-7491-74-9, PIRACETAM (MART.), PIRACETAM [MART.], Naofukang [Chinese], DTXCID3024491, PIRACETAM (EP MONOGRAPH), PIRACETAM [EP MONOGRAPH], Cerebroforte, Avigilen, Nootrop, Norzetam, Axonyl, Geram, Piracetamum [INN-Latin], 2-Pyrrolidone-N-Acetamide, SR-01000076071, Encetrop, Piracetam [USAN:INN:BAN], Prestwick_870, Myocalm (TN), Piracetam (Standard), Piracetam, EP6.0, Spectrum_001421, PIRACETAM [INN], PIRACETAM [JAN], PIRACETAM [MI], PIRACETAM [HSDB], PIRACETAM [USAN], Opera_ID_1766, Prestwick0_000537, Prestwick1_000537, Prestwick2_000537, Prestwick3_000537, Spectrum2_001074, Spectrum3_001523, Spectrum4_000742, Spectrum5_001037, Lopac-P-5295, cid_4843, PIRACETAM [WHO-DD], Lopac0_000949, Oprea1_512927, SCHEMBL20172, BSPBio_000553, BSPBio_002906, KBioGR_001064, KBioSS_001901, Piracetam (JAN/USAN/INN), 2-Oxo-1-pyrrolidinylacetamide, CHEMBL36715, DivK1c_000259, SPECTRUM1502195, Piracetam – Bio-X trade mark, SPBio_001088, SPBio_002474, 2-(2-ketopyrrolidino)acetamide, BPBio1_000609, GTPL4288, BDBM62877, CHEBI:32010, Cl-781, HMS500M21, HY-B0585R, KBio1_000259, KBio2_001901, KBio2_004469, KBio2_007037, KBio3_002406, N06BX03, NINDS_000259, HMS1569L15, HMS1921L12, HMS2092D18, HMS2096L15, HMS2230B24, HMS3262N20, HMS3371G01, HMS3657A05, HMS3713L15, HMS3885I07, Pharmakon1600-01502195, BCP28414, EDC79964, HY-B0585, 2-(2-Oxo-1-pyrrolidinyl)acetamide, Tox21_110229, Tox21_301990, Tox21_500949, BBL028161, CCG-39282, HB0507, NSC758191, s3070, STK535612, AKOS001038683, Tox21_110229_1, 2-(2-Oxo-1-pyrrolidinyl)acetamide #, DB09210, LP00949, SDCCGSBI-0050923.P004, IDI1_000259, NCGC00015821-01, NCGC00015821-03, NCGC00015821-04, NCGC00015821-05, NCGC00015821-06, NCGC00015821-07, NCGC00015821-08, NCGC00015821-10, NCGC00015821-21, NCGC00094253-01, NCGC00094253-02, NCGC00094253-03, NCGC00094253-04, NCGC00255727-01, NCGC00261634-01, AC-33158, AS-13920, BP166248, SY066794, SBI-0050923.P003, DB-019407, AB00052287, EU-0100949, NS00000504, P2880, SW196995-3, 2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide, EN300-17044, Piracetam, VETRANAL(TM), analytical standard, D01914, P 5295, AB00052287_12, AE-641/30117005, Q410069, SR-01000076071-1, SR-01000076071-4, SR-01000076071-6, BRD-K19456237-001-22-7, BRD-K19456237-001-26-8, BRD-K19456237-001-27-6, Z56865289, Piracetam, European Pharmacopoeia (EP) Reference Standard, 2-Oxo-1-pyrrolidineacetamide (2-Oxopyrrolidino)acetamide 2-(2-Oxopyrrolidin-1-yl)acetamide, 231-312-7